Apellis Pharmaceuticals, Inc. 4

Chief Medical Officer Caroline Baumal made a charitable gift of 900 shares of Apellis Pharmaceuticals, Inc. common stock, reducing her direct holdings to 86,525 shares.

On April 29, 2026, Apellis Pharmaceuticals, Inc. Chief Medical Officer Caroline Baumal reported a disposition coded as transaction type “G,” representing a gift of 900 shares of Apellis common stock, characterized in the footnote as a charitable contribution. No sale price or consideration was involved, so there is no cash value realized, and her ownership decreased modestly to 86,525 shares of common stock held directly. A separate note clarifies that her current holdings include 898 shares acquired via an April 30, 2026 ESPP purchase, indicating ongoing participation in the employee stock purchase plan.

Filing Facts

CIK

1492422

Ticker

APLS

Form

4

Source Type

sec

Accession

0001492422-26-000105

Alert Tier

4